Predicting Outcome in Head and Neck Cancer: miRNAs with Potentially Big Effects.

David A ClumpCurtis R PickeringHeath D Skinner

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2018)

A five-miRNA signature for human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) identifies patients at risk for inferior outcomes. Combining established clinical variables with this novel miRNA signature affords an opportunity to personalize and intensify treatment strategies in this high-risk patient population.See related article by Hess et al., p. 1505.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
case report
high grade
big data
metabolic syndrome
adipose tissue
patient reported outcomes
drug induced